Accordingly, in the present study, it was evaluated the ability to reverse liver cirrhosis by treatment with doxazosin and carvedilol, as well as the cotreatment with curcumin, looking to attenuate the toxic effects of these AR blockers. This evidence concerns the gene AR and cirrhosis of liver.